Laboratory sample stability. Is it possible to define a consensus stability function? An example of five blood magnitudes

Gómez Rioja, Rubén; Martínez Espartosa, Débora; Segovia, Marta; Ibarz Escuer, Mercedes; Llopis, María Antonia; Bauçà, Josep Miquel; Marzana, Itziar; Barba, Nuria; Ventura, Monserrat; García del Pino, Isabel; Puente, Juan José; Caballero, Andrea; Gómez, Carolina; García Álvarez, Ana; Alsina, María Jesús; Álvarez, Virtudes

doi:https://doi.org/10.1515/cclm-2017-1189

Visualitza/Obre

027083.pdf (1.335Mb)

Data de publicació

2018-05-05

Autor/a

Gómez Rioja, Rubén

Martínez Espartosa, Débora

Segovia, Marta

Ibarz Escuer, Mercedes

Llopis, María Antonia

Bauçà, Josep Miquel

Marzana, Itziar

Barba, Nuria

Ventura, Monserrat

García del Pino, Isabel

Puente, Juan José

Caballero, Andrea

Gómez, Carolina

García Álvarez, Ana

Alsina, María Jesús

Álvarez, Virtudes

Citació recomanada

Gómez Rioja, Rubén; Martínez Espartosa, Débora; Segovia, Marta; Ibarz Escuer, Mercedes; Llopis, María Antonia; Bauçà, Josep Miquel; ... Álvarez, Virtudes. (2018) . Laboratory sample stability. Is it possible to define a consensus stability function? An example of five blood magnitudes. Clinical Chemistry and Laboratory Medicine, 2018, vol. 56, num. 11, p. 1806-1818. https://doi.org/10.1515/cclm-2017-1189.

Resum

Background: The stability limit of an analyte in a biological sample can be defined as the time required until a measured property acquires a bias higher than a defined specification. Many studies assessing stability and presenting recommendations of stability limits are available, but differences among

them are frequent. The aim of this study was to classify and to grade a set of bibliographic studies on the stability of five common blood measurands and subsequently generate a consensus stability function. Methods: First, a bibliographic search was made for stability studies for five analytes in blood: alanine aminotransferase (ALT), glucose, phosphorus, potassium and prostate specific antigen (PSA). The quality of every study was evaluated using an in-house grading tool. Second, the different conditions of stability were uniformly defined and the percent deviation (PD%) over time for each analyte and condition were scattered while unifying studies with similar conditions. Results: From the 37 articles considered as valid, up to 130 experiments were evaluated and 629 PD% data were included (106 for ALT, 180 for glucose, 113 for phosphorus, 145 for potassium and 85 for PSA). Consensus stability equations were established for glucose, potassium, phosphorus and PSA, but not for ALT. Conclusions: Time is the main variable affecting stability in medical laboratory samples. Bibliographic studies differ in recommedations of stability limits mainly because of different specifications for maximum allowable error. Definition of a consensus stability function in specific conditions can help laboratories define stability limits using their own quality specifications.

URI

http://hdl.handle.net/10459.1/65373

DOI

https://doi.org/10.1515/cclm-2017-1189

És part de

Clinical Chemistry and Laboratory Medicine, 2018, vol. 56, num. 11, p. 1806-1818

Col·leccions

Articles publicats (IRBLleida) [700]
Articles publicats (Infermeria i Fisioteràpia) [121]

Mostrant elements relacionats per títol, autor i matèria.

European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)

Cadamuro, Janne; Lippi, Giuseppe; von Meyer, Alexander; Ibarz Escuer, Mercedes; van Dongen–Lases, Edmee; Cornes, Michael; Nybo, Mads; Vermeersch, Pieter; Grankvist, Kjell; Guimaraes, Joao Tiago; Kristensen, Gunn B.; de la Salle, Barbara; Simundic, Ana-Maria (Croatian Society of Medical Biochemistry and Laboratory Medicine, 2019)

Introduction: No guideline currently exists on how to detect or document haemolysis, icterus or lipemia (HIL) in blood samples, nor on subsequent use of this information. The EFLM WG-PRE has performed a survey for assessing ...
European survey on preanalytical sample handling – Part 1: How do European laboratories monitor the preanalytical phase? On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)

Cadamuro, Janne; Lippi, Giuseppe; von Meyer, Alexander; Ibarz Escuer, Mercedes; van Dongen–Lases, Edmee; Cornes, Michael; Nybo, Mads; Vermeersch, Pieter; Grankvist, Kjell; Guimaraes, Joao Tiago; Kristensen, Gunn B.; de la Salle, Barbara; Simundic, Ana-Maria (Croatian Society of Medical Biochemistry and Laboratory Medicine, 2019)

Introduction: Compared to other activities of the testing process, the preanalytical phase is plagued by a lower degree of standardization, which makes it more vulnerable to errors. With the aim of providing guidelines and ...
Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT

Parisi Capdevila, Eva; Bozić Stanojević, Milica; Ibarz Escuer, Mercedes; Panizo García, Sara; Valcheva, Petya; Coll, Blai; Fernández i Giráldez, Elvira; Valdivielso Revilla, José Manuel (American Physiological Society, 2010)

N-methyl-D-aspartate (NMDA) receptors (NMDAR) are tetrameric amino acid receptors that act as membrane calcium channels. The presence of the receptor has been detected in the principal organs responsible for ...